🔰Fructose, Fatty Liver & Diabetes: Can Unani Medicine Offer a Different Metabolic Map?
“Sugar is sugar.” Modern metabolic research tells us: not exactly. Fructose is handled predominantly by the liver, and experimental and human evidence suggests it can stimulate hepatic de novo lipogenesis more strongly than glucose—particularly in the setting of excess intake and metabolic dysfunction. But here is where an Applied Unani research question becomes fascinating: What if we stop looking at diabetes as merely a “blood sugar disease”? In Unani physiology, digestion is not simply food → glucose. There is a sequential process: Meda → Hazm → absorption → Kabid → Istihala → utilisation/storage The liver (Kabid) occupies a central position in the transformation and distribution of nutritive material. Modern metabolic science is now showing something remarkably relevant: hepatic fat accumulation, insulin resistance and Type 2 Diabetes are metabolically interconnected. MASLD is recognised as a major hepatic manifestation of metabolic dysfunction, and current guidelines s...